Notably, cluster 2 possessed relatively higher expression levels for critical immune checkpoint molecules such as CD44 (a multifunctional player in cancer progression [47]), CD40 (a molecular target symbolizing a higher response rate to immune checkpoint blockade therapy [48]) and LGALS9 (an immunotherapy target that could regulate T cell death [49]). The gene discussed is CD40; the disease is cancer.